Mutation analysis of the PTEN/MMAC1 gene in cancers of the digestive tract

European Journal of Cancer

Volumn 35, Issue 4, 1999, Pages 647-651

  Chang, J G ^a,b   Chen, Y J ^b   Perng, L I ^a   Wang, N M ^a   Kao, M C ^a   Yang, T Y ^a   Chang, C P ^b   Tsai, C H ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b JEN AI HOSPITAL   (Taiwan)

Author keywords

Aberrant transcript; Digestive tract cancer; Mutation analysis; PTEN MMAC1

Indexed keywords

DNA;

ARTICLE; CHROMOSOME 10Q; COLORECTAL CANCER; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DNA SEQUENCE; ESOPHAGUS CANCER; GENE DELETION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; STOMACH CANCER; TUMOR SUPPRESSOR GENE;

COLONIC NEOPLASMS; ESOPHAGEAL NEOPLASMS; GENE DELETION; HUMANS; LOSS OF HETEROZYGOSITY; MUTATION; NEOPLASM PROTEINS; PHOSPHORIC MONOESTER HYDROLASES; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PTEN PHOSPHOHYDROLASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 0033118646     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00411-0     Document Type: Article

References (25)

1. Li J., Yen C., Liaw D., et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science. 275:1997;1943-1947.
2. Steck P.A., Perhouse M.A., Jasser S.A., et al. Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genet. 15:1997;356-362.
3. Liaw D., Marsh D.J., Li J., et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genet. 16:1997;64-67.
4. Marsh D.J., Dahia P.L.M., Zheng Z., et al. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nature Genet. 16:1997;333-334.
5. Peiffer S.L., Herzog T.J., Tribune D.J., Mutch D.G., Gersell D.J., Goodfellow P. Allelic loss of sequences from the long arm of chromosome 10 and replication errrors in endometrial cancers. Cancer Res. 55:1995;1922-1926.
6. Herbst R.A., Weiss J., Ehnis A., Cavenee W.K., Arden K.C. Loss of heterozygosity for 10q22-10qter in malignant melanoma progression. Cancer Res. 54:1994;3111-3114.
7. Ding S.F., Habib N.A. Loss of heterozygosity in liver tumors. J. Hepatol. 22:1995;230-238.
8. Ohta M., Inoue H., Cotticelli M.G., et al. The human FHIT gene, spanning the chromosome 3p14.2 fragile site and renal-carcinoma-associated translocation breakpoint, is abnormal in digestive-tract cancers. Cell. 84:1996;587-597.
9. Li L., Li X., Francke U., Cohen S.N. The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer. Cell. 88:1997;43-154.
10. Lee H.H., Chang J.G., Lin S.P., Chao H.T., Yang M.L., Ng H.T. Rapid detection of trisomy 21 by homologous gene quantitative PCR (HGQ-PCR). Hum. Genet. 99:1997;364-367.
11. Chen Y.J., Chen P.H., Lee M.D., Chang J.G. Aberrant FHIT transcripts in cancerous and corresponding non-cancerous lesions of the digestive tract. Int. J. Cancer. 72:1997;355-358.
12. Chen Y.J., Chang J.G., . Shih L.S., et al. Frequent detection of aberrant RNA transcripts of the CDKN2 gene in human gastric adenocarcinoma. Int. J. Cancer. 71:1997;350-354.
13. Chang J.G., Jong Y.J., Huang J.M., et al. Molecular basis of spinal muscular atrophy in Chinese. Am. J. Hum. Genet. 57:1995;1503-1505.
14. Lee M.P., Feinberg A.P. Aberrant splicing but not mutations of TSG101 in human breast cancer. Cancer Res. 57:1997;3131-3134.
15. Myers M.P., Stolarov J.P., Eng C., et al. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual specificity phosphatase. Proc. Natl. Acad. Sci. USA. 94:1997;9052-9057.
16. Rhei E., Kang L., Bogomolniy F., Federici M.G., Borgen P.I., Boyd J. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res. 57:1997;3657-3659.
17. Tashiro H., Blazes M.S., Wu R., et al. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res. 57:1997;3935-3940.
18. Guldberg P., Straten P.T., Birck A., Ahrenkiel V., Kirkin A.F., Zeuthen J. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res. 57:1997;3660-3663.
19. Wang S.I., Puc J., Li J., et al. Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res. 57:1997;4183-4186.
20. Bostrom J., Cobbers J.M.J.L., Wolter M., et al. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. Cancer Res. 58:1998;29-33.
21. Dahia P.L.M., Marsh D.J., Zheng Z., et al. Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Res. 57:1997;4710-4713.
22. Suzuki H., Freile D., Nusskern D.R., et al. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res. 58:1998;204-209.
23. Cairns P., Okami K., Halachmi S., et al. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res. 57:1997;4997-5000.
24. Teng D.H.F., Hu R., Lin H., et al. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res. 57:1997;5221-5225.
25. Steiner P., Barnes D.M., Harris W.H., Weinberg R.A. Absence of rearrangements in the tumor susceptibility gene TSG101 in human breast cancer. Nature Genet. 16:1997;332-333.